Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Microbiol Immunol Infect ; 50(2): 224-231, 2017 Apr.
Article in English | MEDLINE | ID: mdl-26055688

ABSTRACT

BACKGROUND/PURPOSE: Efflux pumps are one of the major mechanisms of antimicrobial resistance in Acinetobacter baumannii. This study aimed to understand the distribution of different types of pump genes in clinical isolates of multidrug-resistant A. baumannii (MDRAB) and to reveal the relationship between their presence and expression with antimicrobial resistance. METHODS: MDRAB isolates were collected from five hospitals in Taiwan. Different categories of pump genes, including adeB, adeJ, macB, abeM, abeS, emrA-like, emrB-like, and craA, were chosen, and their presence in the collected isolates was determined. Three induced resistant strains of A. baumannii ATCC 17978 to tigecycline, imipenem, and amikacin were also included. The expressions of the selected pump genes were determined using quantitative reverse transcription-polymerase chain reaction. RESULTS: Twenty-one MDRAB clinical isolates were obtained from five hospitals. All of the studied pump genes were present in the collected MDRAB isolates except one isolate that lacked the emrA-like gene. The gene expression of these efflux pumps was variable among the strains. The upregulation of the adeB, adeJ, and macB genes was responsible for tigecycline resistance, and the increased abeS expression was strongly related to amikacin resistance. Of all the antibiotics studied, tigecycline was the strongest inducer of gene expression for many efflux pumps in A. baumannii. CONCLUSION: Efflux pump genes are universally present in the collected clinical MDRAB isolates. The upregulation of the adeB, adeJ, macB and abeS genes is more related with antibiotic resistance.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Membrane Transport Proteins/genetics , Acinetobacter baumannii/metabolism , Anti-Bacterial Agents/pharmacokinetics , Bacterial Proteins/metabolism , DNA, Bacterial/analysis , Drug Resistance, Multiple, Bacterial , Genes, Bacterial , Humans , Membrane Proteins/genetics , Membrane Transport Proteins/metabolism , Microbial Sensitivity Tests , RNA, Bacterial/analysis
2.
Appl Microbiol Biotechnol ; 101(2): 771-781, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27771740

ABSTRACT

Terminal disinfection and daily cleaning have been performed in hospitals in Taiwan for many years to reduce the risks of healthcare-associated infections. However, the effectiveness of these cleaning approaches and dynamic changes of surface microbiota upon cleaning remain unclear. Here, we report the surface changes of bacterial communities with terminal disinfection and daily cleaning in a medical intensive care unit (MICU) and only terminal disinfection in a respiratory care center (RCC) using 16s ribosomal RNA (rRNA) metagenomics. A total of 36 samples, including 9 samples per sampling time, from each ward were analysed. The clinical isolates were recorded during the sampling time. A large amount of microbial diversity was detected, and human skin microbiota (HSM) was predominant in both wards. In addition, the colonization rate of the HSM in the MICU was higher than that in the RCC, especially for Moraxellaceae. A higher alpha-diversity (p = 0.005519) and a lower UniFrac distance was shown in the RCC due to the lack of daily cleaning. Moreover, a significantly higher abundance among Acinetobacter sp., Streptococcus sp. and Pseudomonas sp. was shown in the RCC compared to the MICU using the paired t test. We concluded that cleaning changes might contribute to the difference in diversity between two wards.


Subject(s)
Bacteria/classification , Bacteria/isolation & purification , Disinfection/methods , Environmental Microbiology , Hospitals , Housekeeping, Hospital/methods , Bacteria/genetics , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Humans , Intensive Care Units , Metagenomics , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Taiwan
3.
Microb Drug Resist ; 20(5): 410-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24833435

ABSTRACT

This study employed genomewide analysis to investigate potential resistance mechanisms in Acinetobacter baumannii following imipenem exposure. Imipenem-selected mutants were generated from the imipenem-susceptible strain ATCC 17978 by multistep selection resistance. Antibiotic susceptibilities were examined, and the selected mutants originated from the ATCC 17978 strain were confirmed by pulsed-field gel electrophoresis. The genomic sequence of a resistant mutant was analyzed using a next-generation sequencing platform, and genetic recombination was further confirmed by PCR. The result showed that phenotypic resistance was observed with carbapenem upon exposure to various concentrations of imipenem. Genomewide analysis showed that ISAba1 transposition was initiated by imipenem exposure at concentrations up to 0.5 mg/L. Transposition of ISAba1 upstream of blaOXA-95 was detected in all the selected mutants. The expression of blaOXA-95 was further analyzed by quantitative PCR, and the results demonstrated that a 200-fold increase in gene expression was required for resistance to imipenem. This study concluded that imipenem exposure at a concentration of 0.5 mg/L mediated the transposition of ISAba1 upstream of the blaOXA-95 gene and resulted in the overexpression of blaOXA-95 gene, which may play a major role in the resistance to imipenem in A. baumannii.


Subject(s)
Acinetobacter baumannii/genetics , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , DNA Transposable Elements , Gene Expression Regulation, Bacterial , Imipenem/pharmacology , beta-Lactamases/genetics , Acinetobacter Infections/drug therapy , Acinetobacter Infections/microbiology , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/enzymology , Bacterial Proteins/metabolism , Base Sequence , Electrophoresis, Gel, Pulsed-Field , Genotype , Humans , Molecular Sequence Data , Mutagenesis, Insertional , Phenotype , Plasmids/chemistry , Plasmids/metabolism , RNA, Ribosomal, 16S/genetics , beta-Lactamases/metabolism
4.
Ann Lab Med ; 33(4): 242-7, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23826559

ABSTRACT

BACKGROUND: The aims of this study were to understand the molecular epidemiology of integron-associated gene cassettes in Acinetobacter baumannii across four hospitals in northern Taiwan and to clarify the relationship between the presence of integrons and antibiotic-resistant phenotypes. METHODS: Sixty-five A. baumannii isolates, collected from the patients of four regional hospitals in northern Taiwan in 2009, were tested for the presence of integrons and their associated gene cassettes. The susceptibility difference between integron-positive and integron-negative A. baumannii strains was analyzed. Antibiotic-resistant phenotypes among A. baumannii with different types of gene cassette array combinations were also compared. RESULTS: Around 72% of the A. baumannii isolates carried class 1 integrase genes. Despite this, only three gene cassette arrays were found in the integrons. Integron-positive strains were significantly more resistant to all the tested antibiotics than the integrase-negative strains. All the four types of A. baumannii with different gene cassette array combinations were multidrug-resistant in nature. Gene cassette array aacA4-catB8-aadA1 existed in all the integron-positive A. baumannii isolates. Repetitive-sequence-based PCR (rep-PCR) results revealed the prevalence of one major cluster of imipenem-resistant A. baumannii strains (84%) in the four regional hospitals. CONCLUSIONS: The presence of integrons with associated antimicrobial resistance gene cassettes can be used as a representative marker of multidrug resistance in A. baumannii. Some prevalent gene cassette arrays may exist among epidemiologically unrelated A. baumannii strains.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/genetics , Integrons/genetics , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/isolation & purification , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , DNA, Bacterial/analysis , Drug Resistance, Bacterial , Humans , Imipenem/pharmacology , Integrases/genetics , Microbial Sensitivity Tests , Multiplex Polymerase Chain Reaction , Taiwan/epidemiology
5.
J Microbiol Immunol Infect ; 44(1): 39-44, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21531351

ABSTRACT

BACKGROUND: The distribution and characterization of OXA-type carbapenemases in Acinetobacter sp in Taiwan has less been reported. The aim of the study was to investigate the molecular epidemiology and OXA-type carbapenemase genes in a regional hospital in Taiwan. METHODS: Imipenem-resistant Acinetobacter sp were collected between 2005 and 2007 in a regional hospital. Genotyping was performed by pulsed-field gel electrophoresis. OXA-type carbapenemase genes were determined by multiplex polymerase chain reaction (PCR) and gene sequencing. RESULTS: A total of 136 isolates were collected. Fifty-six pulsotypes were identified. None of the pulsotypes established predominance throughout the 3-year period. Multiplex PCR of blaOXA genes showed that 99% (135/136) of the Acinetobacter sp possessed blaOXA51-like genes. The coexistences of blaOXA51-like/blaOXA-23-like and blaOXA51-like/blaOXA-24-like were detected in 19% (26/136) and 1% (2/136) of the isolates, respectively. Among blaOXA-23-like gene-carrying isolates, two isolates (Pulsotypes 18 and 20) were found in 2006 and the remainder (n=24), including Pulsotypes 27 (n=18), 29 (n=1), 52 (n=3), and 53 (n=2), were found in 2007. Sequencing performed on the 26 representative isolates confirmed the presence of the blaOXA-23 carbapenemase gene. Analysis of the genetic content of blaOXA-23 showed that these genes were presumably chromosomal and associated with the upstream-located insertion sequence ISAba1. CONCLUSIONS: The emergence and imminent widespread of blaOXA-23-carrying imipenem-resistant Acinetobacter sp appeared in Taiwan during the period from 2006 to 2007.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter/drug effects , Anti-Bacterial Agents/pharmacology , Cross Infection/epidemiology , Imipenem/pharmacology , beta-Lactam Resistance , beta-Lactamases/genetics , Acinetobacter/enzymology , Acinetobacter/genetics , Acinetobacter/isolation & purification , Acinetobacter Infections/microbiology , Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field , Genotype , Hospitals, District , Humans , Molecular Typing , Multiplex Polymerase Chain Reaction , Sequence Analysis, DNA , Taiwan/epidemiology
6.
Am J Infect Control ; 37(9): e1-3, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19576662

ABSTRACT

We conducted a case-controlled study in a regional teaching hospital in Taiwan to investigate the clinical features and molecular epidemiology of multidrug-resistant Acinetobacter calcoaceticus-A baumannii (MDR Acb) complex. Case patients had higher mortality than controls did. MDR Acb complex acquisition risk factors include longer hospital stays, higher ratio of nasogastric tube and Foley catheter use, and more carbapenem use. All available isolates were divided into 36 subtypes by pulsed-field gel electrophoresis. The proportion of the same subtypes with their appearance within 1 and 2 months was 62.5% and 87.5%, respectively. We concluded that many different MDR Acb complex clones could be found in a hospital and that the same clones often spread on a small scale within a short period of time if no outbreaks noted.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter Infections/pathology , Acinetobacter baumannii/isolation & purification , Acinetobacter calcoaceticus/isolation & purification , Cross Infection/epidemiology , Cross Infection/pathology , Drug Resistance, Multiple, Bacterial , Acinetobacter Infections/microbiology , Acinetobacter Infections/mortality , Acinetobacter baumannii/classification , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/genetics , Acinetobacter calcoaceticus/classification , Acinetobacter calcoaceticus/drug effects , Acinetobacter calcoaceticus/genetics , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Case-Control Studies , Cluster Analysis , Cross Infection/microbiology , Cross Infection/mortality , DNA Fingerprinting , Electrophoresis, Gel, Pulsed-Field , Female , Genotype , Hospitals, Teaching , Humans , Male , Middle Aged , Molecular Epidemiology , Risk Factors , Taiwan
SELECTION OF CITATIONS
SEARCH DETAIL
...